Bosnia and Herzegovina vs Iran, Islamic Republic of: Previously treated cases tested for RR-/MDR-TB
Bosnia and Herzegovina
89.0%
in 2024
Iran, Islamic Republic of
89.0%
in 2024
Bosnia and Herzegovina rank
87th
Iran, Islamic Republic of rank
87th
Previously treated cases tested for RR-/MDR-TB over time
- Bosnia and Herzegovina
- Iran, Islamic Republic of
How they compare
Bosnia and Herzegovina currently reports 89.0% against 89.0% in Iran, Islamic Republic of, a difference of 0.0%.
The two have swapped places 3 times across 19 shared years of data; in 2005 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 87th and Iran, Islamic Republic of ranks 87th of 180 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.8% | 20.4% | 63.4% | Bosnia and Herzegovina |
| 2010s | 63.6% | 46.7% | 16.9% | Bosnia and Herzegovina |
| 2020s | 91.0% | 71.2% | 19.8% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bosnia and Herzegovina or Iran, Islamic Republic of?
- Bosnia and Herzegovina, at 89.0% against 89.0% in Iran, Islamic Republic of as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bosnia and Herzegovina and Iran, Islamic Republic of?
- 0.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Iran, Islamic Republic of?
- 19 years are reported by both, from 2005 to 2024.
- How do Bosnia and Herzegovina and Iran, Islamic Republic of rank globally for previously treated cases tested for rr-/mdr-tb?
- Bosnia and Herzegovina ranks 87th and Iran, Islamic Republic of ranks 87th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.